Stay updated on Safety and Efficacy of Ibrutinib and Pembrolizumab in CLL/MCL Clinical Trial

Sign up to get notified when there's something new on the Safety and Efficacy of Ibrutinib and Pembrolizumab in CLL/MCL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety and Efficacy of Ibrutinib and Pembrolizumab in CLL/MCL Clinical Trial page

  1. Check
    today
    Change Detected
    Difference
    0.4%
    Check dated 2025-05-08T13:54:41.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content or functionality of the page.
    Difference
    0.1%
    Check dated 2025-05-01T06:22:04.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Difference
    0.4%
    Check dated 2025-04-24T01:18:45.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect a new version of the study protocol for a clinical trial evaluating the safety and efficacy of ibrutinib and pembrolizumab in patients with Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL). Key details such as the study's non-randomized design, the allocation of patients to cohorts, and the involvement of collaborators have been clarified.
    Difference
    56%
    Check dated 2025-04-16T20:37:08.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.5%
    Check dated 2025-04-09T14:36:54.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Difference
    0.4%
    Check dated 2025-04-02T00:20:01.000Z thumbnail image

Stay in the know with updates to Safety and Efficacy of Ibrutinib and Pembrolizumab in CLL/MCL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety and Efficacy of Ibrutinib and Pembrolizumab in CLL/MCL Clinical Trial page.